DXC Divests Another Business Line

DXC Divests Another Business Line

DXC Technology (NYSE: DXC) has spent 2020 trying to streamline its business portfolio. When Mike Salvino took over as CEO of DXC in September 2019, he announced during his first earnings call that the company was planning strategic alternatives, including the possible divestiture of three of its non-core assets, which made up roughly 25% of the company’s revenue. And last week, DXC announced another milestone in that campaign. The company revealed it is selling its healthcare software provider business to Dedalus Group for $525 million. DXC’s healthcare software business is an open digital health platform that helps improve care outcomes by delivering contextual and... Read More »
DXC Divests Another Business Line

DXC Technology Divests State & Local HHS Business

When Mike Salvino took over as CEO of DXC Technology (NYSE: DXC) in September 2019, he announced during his first earnings call that the company was planning strategic alternatives, including the possible divesture of three of its non-core assets, which made up roughly 25% of the company’s revenue. One of those segments included its U.S. state and local health and human services business (HHS business), which DXC managed to divest last week to Veritas Capital Management LLC for $5 billion in cash. DXC’s HHS business is an end-to-end provider of technology solutions critical to the administration and operations of health programs. The business facilitates performance... Read More »